Medical Tests
Explore lab tests, blood work, and imaging exams with plain-language preparation and overview pages.
Browse Directory Sections
All medical tests (102,751)
Other
ADB-4en-PINACA [Mass/volume] in Urine by Confirmatory method
Other
ADB-4en-PINACA [Presence] in Urine by Confirmatory method
Other
ADB-4en-PINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method
Other
ADB-BUTINACA [Mass/volume] in Urine by Confirmatory method
Other
ADB-BUTINACA [Presence] in Urine by Confirmatory method
Other
ADB-BUTINACA/Creatinine [Mass Ratio] in Urine by Confirmatory method
Other
ADB-PINACA pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Other
ADBICA N-4-hydroxypentyl (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Other
ADBICA N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Other
ADHD action plan
Other
ADHD diagnostic rating scale interpretation [Vanderbilt ADHD]
Other
ADHD hyperactive symptoms mean score [Calculated]
Other
ADHD hyperactive symptoms mean score percent difference [Calculated]
Other
ADHD hyperactive symptoms severity
Other
ADHD inattentive symptoms mean score [Calculated]
Other
ADHD inattentive symptoms mean score percent difference [Calculated]
Other
ADHD inattentive symptoms severity
Other
ADHD question consistency score
Other
ADHD screening report
Other
ADHD type
Other
ADL and IADLs
Other
ADL and IADLs - discharge during assessment period [CMS Assessment]
Other
ADL and IADLs - follow-up [OASIS-C]
Other
ADL functional rehabilitation potential Set
Other
ADL functional/rehabilitation potential - addressed in care plan [MDSv3]
Other
ADL functional/rehabilitation potential - care area triggered [MDSv3]
Other
ADL or IADL assistance frequency from any caregiver during assessment period [CMS Assessment]
Other
ADL patterns Set
Other
ADL self performance or support (quarterly) Set
Other
ADL self performance or support Set
Other
ADL-rehabilitation trigger A [Minimum Data Set]
Other
ADL-rehabilitation trigger B [Minimum Data Set]
Blood test
ADNFLE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ADRA2A gene c.-1252G>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ADRB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Other
AE 1 Ag [Presence] in Tissue by Immune stain
Other
AE 3 Ag [Presence] in Tissue by Immune stain
Other
AED use prior to EMS arrival NEMSIS
Blood test
AGA gene [Interpretation] in Serum
Blood test
AGA gene [Likelihood] in Serum by Calculation
Blood test
AGA gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
AGA gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Blood test
AGL gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
AGTR1 gene c.1166A>C [Genotype] in Blood by Molecular genetics method Nominal
Blood test
AGXT gene deletion and duplication mutation analysis in Blood or Tissue by MLPA
Blood test
AGXT gene deletion+duplication and full mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
AGXT gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Blood test
AGXT gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Other
AH-7921 [Mass/volume] in Urine by Confirmatory method
Other
AH-8529 [Mass/volume] in Urine by Confirmatory method
Other
AH-8533 [Mass/volume] in Urine by Confirmatory method
Blood test
AHCY gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
AHCY gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Blood test
AIP gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
AIP gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Blood test
AIRE gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Other
AJCC cancer staging manual [PhenX]
Other
AKB48 N-pentanoate (synthetic cannabinoid metabolite) [Presence] in Urine by Confirmatory method
Blood test
AKT1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
AKT1 gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALAS2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALDH3A2 gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
ALDOB gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALDOB gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
Blood test
ALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALK gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALK gene rearrangements [Interpretation] in Blood or Tissue by FISH Narrative
Blood test
ALK gene rearrangements [Presence] in Blood or Tissue by FISH
Blood test
ALOX3+ALOX12B gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
Blood test
ALPL gene full mutation analysis in Blood or Tissue by Sequencing
Blood test
ALPL gene mutation analysis limited to known familial mutations in Blood or Tissue by Molecular genetics method
Other
ALPRAZolam [Mass/mass] in Hair
Other
ALPRAZolam [Mass/mass] in Meconium
Other
ALPRAZolam [Mass/mass] in Meconium by Confirmatory method
Other
ALPRAZolam [Mass/mass] in Stool by Confirmatory method
Other
ALPRAZolam [Mass/mass] in Tissue
Other
ALPRAZolam [Mass/mass] in Tissue by Confirmatory method
Blood test
ALPRAZolam [Mass/volume] in Blood
Blood test
ALPRAZolam [Mass/volume] in Blood by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Body fluid
Other
ALPRAZolam [Mass/volume] in Body fluid by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Gastric fluid
Other
ALPRAZolam [Mass/volume] in Saliva (oral fluid)
Other
ALPRAZolam [Mass/volume] in Saliva (oral fluid) by Confirmatory method
Blood test
ALPRAZolam [Mass/volume] in Serum or Plasma
Blood test
ALPRAZolam [Mass/volume] in Serum or Plasma --trough
Blood test
ALPRAZolam [Mass/volume] in Serum or Plasma by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Specimen
Other
ALPRAZolam [Mass/volume] in Stool
Other
ALPRAZolam [Mass/volume] in Urine
Other
ALPRAZolam [Mass/volume] in Urine by Confirmatory method
Other
ALPRAZolam [Mass/volume] in Vitreous fluid
Other
ALPRAZolam [Mass] of Dose
Other
ALPRAZolam [Measurement] in Saliva (oral fluid)
Blood test
ALPRAZolam [Measurement] in Serum or Plasma
Other
ALPRAZolam [Measurement] in Urine
Blood test
ALPRAZolam [Moles/volume] in Serum or Plasma
Other
ALPRAZolam [Moles/volume] in Specimen
Other
ALPRAZolam [Presence] in Cord tissue by Confirmatory method
Other
ALPRAZolam [Presence] in Cord tissue by Screen method